U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435480) titled 'Evaluation of Irisin Hormone as a Novel Diagnostic Marker for Early Detection and Progression of Diabetic Nephrophathy Patients' on Feb. 20.
Brief Summary: Study the relation between irisin level and progression of diabetic nephropathy and its early detection.
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Diabetic Nephropathies
Intervention:
DIAGNOSTIC_TEST: HBa1c
Rapid method for detection of diabetes
DIAGNOSTIC_TEST: glucose
accurate method for diabetes
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sohag University
Information provided by (Responsible Party): Gehad Hamdy Abdelmegid, Sohag University...